September 14, 2023
New gene therapy company created and funded by Oxford Science Enterprises, Harrington Discovery Institute and Old College Capital in partnership with six leading scientists from the world-renowned UK Respiratory Gene Therapy Consortium (GTC) AlveoGene initially aims to leverage proprietary lentiviral gene therapy platform...
Continue Reading
January 01, 2019
Accelerating Cures for a World in Need Continue Reading
January 01, 2018
Breakthrough Discoveries that Create Impact Continue Reading
January 01, 2017
First Five Years: Advancing Discoveries into Medicines Continue Reading
January 01, 2015
Momentum: Moving Medicine Forward Continue Reading
January 01, 2012
Celebrating a Year of Accomplishments Continue Reading